MEDTECH
Fibronostics, a global leader in non-invasive, AI-driven diagnostic testing for *MAFLD/MASH patients, announced today a strategic...
EVENTS
NEW YORK and SINGAPORE, June 15, 2022 /PRNewswire/ — Fibronostics, a global leader in non-invasive, AI-driven diagnostics for NASH patients,...
DIGITAL CLINICAL SOLUTION
This final part of the video informative series focuses on LIVERFASt, a non-invasive AI...
NEW YORK & SINGAPORE – August 24, 2020 – Fibronostics, a global company providing non-invasive, algorithmic...
NEW YORK, August 3, 2020 – Fibronostics, a global diagnostics company, providing non-invasive, algorithmic diagnostics to...